|
 |
Obchodní název |
|
|
Trade names are indicative and excipients composition can be different depending on the country and manufacturers
|
|
Bolentax |
Mexiko |
|
Clasina |
Ekvádor, Kolumbie, Peru |
|
Clasina |
Kolumbie |
|
Clexan |
ÿecko |
|
Clexane |
äpanÏlsko, Argentina, Austrálie, Belgie, BrazÌlie, Chile, Egypt, Ekvádor, Írán, Irsko, Itálie, Japonsko, Kolumbie, Lucembursko, Malajsie, Mexiko, NÏmecko, Nizozemsko, nový Zéland, Peru, Polsko, Rumunsko, Saúdská Arábie, Spojené arabské emiráty, Švýcarsko, Turecko, Velká Británie, Venezuela |
|
Cutenox |
BrazÌlie, Peru |
|
Dilutol |
äpanÏlsko, Argentina, Ekvádor |
|
Dynalin |
Indie |
|
Enoparin |
Venezuela |
|
Enoxalon |
Chile |
|
Enoxanorth |
Argentina |
|
Enoxatal |
Kolumbie |
|
Hemofagin |
Chile |
|
Inhixa |
NÏmecko |
|
Klexane |
Dánsko, Finsko, NÏmecko, Norsko, Švédsko |
|
Lovenox |
Francie, Kanada, Maroko, NÏmecko, Portugalsko, Rakousko, Tunisko, USA |
|
Lowparin |
Egypt |
|
Nurox |
Chile, Ekvádor, Kolumbie |
|
|
 |
 |
Odkazy : Enoxaparin sodium |
|
|
typ |
uveřejnění |
| 311 |
noviny |
Newborn AL, Kessler JM, Joyner KA.
Compatibility and activity of enoxaparin sodium in 0.9% sodium chloride injection for 48 hours.
Am J Health-Syst Pharm 1996 ; 53: 167-169. |
| 811 |
noviny |
Charland SL, Davis DD, Tillman DJ.
Activity of enoxaparin sodium in tuberculin syringes for 10 days.
Am J Health-Syst Pharm 1998 ; 55: 1296-1298. |
| 1893 |
noviny |
Dager WE, Gosselin RC, King JF, Christensen CL, Owings JT, Larkin EC.
Anti-Xa stability of diluted enoxaparin for use in pediatrics.
Ann Pharmacotherapy 2004 ; 38: 569-573. |
| 2231 |
noviny |
de Jongh R, Hens R, Basma V, mouton JW, Tulkens PM, Carryn S.
Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection.
J Antimicrob Chemother 2008 ; 61, 2: 382-388. |
| 3643 |
Laboratoř |
Gentamicin sulphate (Cidomycin®) - Summary of Product Characteristics
Sanofi 2015 |
| 4413 |
noviny |
Moffett B.S, Dinh K, Placencia J, Pelkey G, Rocky Hui S-K, Teruya J.
Stability and Sterility of Enoxaparin 8 mg/mL Subcutaneous Injectable Solution.
J Pediatr Pharmacol Ther 2016 ; 21, 4: 322-326. |
| 4985 |
Laboratoř |
ENOXAPARINE ARROW 10 000 UI (100 mg)/1 mL, solution injectable en seringue préremplie - Résumé des caractéristiques du produit.
ARROW GENERIQUES 2023 |
|
|
